Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Giannantoni A et al. – The new beneficial effect that we report in a small study sample encourages larger trials to confirm botulinum toxin type A injection into the detrusor muscle as an effective and safe treatment for refractory overactive bladder symptoms and detrusor overactivity related to Parkinson's disease and multiple system atrophy.

Related Articles

Fesoterodine for the Treatment of Overactive Bladder
Annals of Pharmacotherapy, 11/18/09    Relevance Score: 69%

The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09    Relevance Score: 69%

The relationship between sleep apnea and overactive bladder
Current Urology Reports, 11/17/09    Relevance Score: 68%

Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
BJU International, 10/13/09    Relevance Score: 68%

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09    Relevance Score: 67%

Today in Voiding Dys/Incontinence...keeping you current

Predicting Success in the Endoscopic Management of Pediatric Vesicoureteral Reflux
Urology, 12/08/09

Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in the Indian population
Indian Journal of Urology, 12/08/09

Minimally Invasive Therapy of Lower Urinary Tract Symptoms
Urologic Clinics of North America, 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address